Cargando…
SOX6 blocks the proliferation of BCR-ABL1(+) and JAK2V617F(+) leukemic cells
SOX6 is a HMG-box transcription factor expressed in a wide range of tissues. Recent data show that SOX6 expression is altered in different cancers, in the majority of cases being downregulated. To date, no data are available about SOX6 role in hematological malignancies. Here we demonstrate that SOX...
Autores principales: | Barbarani, Gloria, Fugazza, Cristina, Barabino, Silvia M. L., Ronchi, Antonella E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399316/ https://www.ncbi.nlm.nih.gov/pubmed/30833651 http://dx.doi.org/10.1038/s41598-019-39926-4 |
Ejemplares similares
-
Allelic Expression Imbalance of JAK2 V617F Mutation in BCR-ABL Negative Myeloproliferative Neoplasms
por: Kim, Hye-Ran, et al.
Publicado: (2013) -
Emergence of BCR-ABL1 Chronic Myeloid Leukemia in a JAK2-V617F Polycythemia Vera
por: Lorenzo, Mariana, et al.
Publicado: (2020) -
Unravelling pathways downstream Sox6 induction in K562 erythroid cells by proteomic analysis
por: Barbarani, Gloria, et al.
Publicado: (2017) -
Concomitant JAK2 V617F-positive polycythemia vera and BCR-ABL-positive chronic myelogenous leukemia treated with ruxolitinib and dasatinib
por: Zhou, A, et al.
Publicado: (2015) -
Comparative study of different methodologies to detect the JAK2 V617F mutation in chronic BCR-ABL1 negative myeloproliferative neoplasms
por: Didone, Alline, et al.
Publicado: (2015)